Treatment combined with bone marrow transplantation for advanced neuroblastoma: An analysis of patients who were pretreated intensively with the protocol of the study group of Japan

Medical and Pediatric Oncology

Volumn 24, Issue 3, 1995, Pages 181-187

  Ohnuma, Naomi ^a   Takahashi, Hideyo ^a   Kaneko, Michio ^b   Uchino, Jun‐Ichi ^c   Takeda, Takeo ^d   Iwafuchi, Makoto ^e   Ohhira, Mutsuro ^f   Nishihira, Hirokazu ^g   Mugishima, Hideo ^h   Yokoyama, Jotaro ⁱ   Okada, Akira ^j   Nagahara, Noboru ^k   Taguchi, Nobuyuki ^l   Tsuchida, Yoshiaki ^m  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d HOKKAIDO CANCER CENTER   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^h NIHON UNIVERSITY   (Japan)

ⁱ KEIO UNIVERSITY   (Japan)

^j OSAKA UNIVERSITY   (Japan)

^k Department of Pediatrics   (Japan)

^l NATIONAL CHILDREN S HOSPITAL   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

bone marrow transplantation; chemotherapy; neuroblastoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; ETOPOSIDE; MELPHALAN; NEURON SPECIFIC ENOLASE; NIMUSTINE; PIRARUBICIN; VINCRISTINE;

ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; HEMORRHAGIC CYSTITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; ONCOGENE; OTOTOXICITY; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; HUMAN; INFANT; JAPAN; NEUROBLASTOMA; NIMUSTINE; PROGNOSIS; REMISSION INDUCTION; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; VINCRISTINE;

EID: 0028872733     PISSN: 00981532     EISSN: 1096911X     Source Type: Journal    
DOI: 10.1002/mpo.2950240308     Document Type: Article

References (16)

1. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy: A report from the study group of Japan
2. Staging of neuroblastoma
3. A proposed staging for children with neuroblastoma
4. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma
5. High dose melphalan with autologous bone marrow for treatment of advanced neuroblastoma
6. Nonparametric estimation from incomplete observations
7. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
8. Repeated high‐dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma
9. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup?
10. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation and allogenic or autologous marrow reconstruction
11. Delayed surgery and bone marrow transplantation for widespread neuroblastoma
12. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma
13. Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory “debulking” treatments
14. Serum neuron‐specific enolase in children with neuroblastoma: Relationship to stage and disease course
15. Amplification of N‐myc in untreated human neuroblastomas co. relates with advanced disease stage
16. Association of multiple copies of the M‐myc oncogene with rapid progression of neuroblastomas